Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study

Blood biomarkers for dementia have the potential to identify preclinical disease and improve participant selection for clinical trials. Machine learning is an efficient analytical strategy to simultaneously identify multiple candidate biomarkers for dementia. We aimed to identify important candidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Honghuang, Himali, Jayandra J., Satizabal, Claudia L., Beiser, Alexa S., Levy, Daniel, Benjamin, Emelia J., Gonzales, Mitzi M., Ghosh, Saptaparni, Vasan, Ramachandran S., Seshadri, Sudha, McGrath, Emer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100323/
https://www.ncbi.nlm.nih.gov/pubmed/35563811
http://dx.doi.org/10.3390/cells11091506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100323/
https://www.ncbi.nlm.nih.gov/pubmed/35563811
http://dx.doi.org/10.3390/cells11091506

Ejemplares similares